1-naphthyl alpha-truxillate

an antinociceptive agent; structure in first source

Also Known As:

SBFI-26

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Stomach Neoplasms (Stomach Cancer) 08/01/2021 - "The FABP5 inhibitor SBFI-26 suppressed the proliferation and promoted the apoptosis of gastric cancer (GC) cells and interfered with the Hippo signaling pathway by inhibiting YAP1. "
2.	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/01/2023 - "FABP5 inhibitor SBFI-26 regulates FOXM1 expression and Wnt signaling pathway in ovarian granulosa cell of patients with polycystic ovary syndrome."